Coil Hysteroscopic Tubal Occlusion in the Treatment of Hydrosalpinx
1 other identifier
interventional
80
1 country
1
Brief Summary
this study is to investigate the success rate of proximal tubal occlusion with coil devices in women with hydrosalinx and to observe there pregnancy rate with IVF-ET.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2015
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2015
CompletedFirst Submitted
Initial submission to the registry
May 19, 2016
CompletedFirst Posted
Study publicly available on registry
January 10, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2018
CompletedJanuary 10, 2018
December 1, 2017
2.6 years
May 19, 2016
January 3, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pregnancy rate
Patients will be followed up with the pregnancy outcomes after the tubal occlusion
2 months after IVF-ET
Study Arms (1)
tubal occlusion
EXPERIMENTALFiber coils were inserted into the interstitial part of fallopian tubes, and IVF-ET was taken out in the following.
Interventions
Fiber platinum coil were inserted into the interstitial part of the tubes of patients in hydrosalpinx through hysteroscopy
Eligibility Criteria
You may qualify if:
- Have unilateral or bilateral hydrosalpinxs as evidenced by HSG.
- laparoscopic surgery was considered to be contraindicated because of ex-tensive pelvic adhesions.
- Are willing to undergo a hysterosalpingogram (HSG) 1 months after fiber platinum coil placement to confirm proximal tubal occlusion.
- Are willing to participate in this clinical study .Are able to comprehend and give informed consent for participation in this study.
- Have read, understood and signed an informed consent form .
You may not qualify if:
- Active or recent upper or lower pelvic infection
- Known hypersensitivity to nickel as confirmed by skin test
- Known allergy to contrast media Pregnancy or suspected pregnancy
- Evidence of intrauterine abnormalities such as submucous fibroids, polyps, intrauterine adhesions or presence of a uterine septum
- Poor general or gynecologic health
- Inability or refusal to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
the 1st Affiliated Hospital of Wenzhou Medical College
Wenzhou, Zhejiang, 325000, China
Related Publications (2)
Matorras R, Rabanal A, Prieto B, Diez S, Brouard I, Mendoza R, Exposito A. Hysteroscopic hydrosalpinx occlusion with Essure device in IVF patients when salpingectomy or laparoscopy is contraindicated. Eur J Obstet Gynecol Reprod Biol. 2013 Jul;169(1):54-9. doi: 10.1016/j.ejogrb.2013.02.008. Epub 2013 Apr 2.
PMID: 23561020BACKGROUNDWu YC, Huang XF, Yang HY, Chen X, Wang PY, Hu Y, Lin F. Fibered platinum coil: A novel option for the patients of hydrosalpinx with laparoscopic contradiction. Eur J Obstet Gynecol Reprod Biol. 2018 Oct;229:179-184. doi: 10.1016/j.ejogrb.2018.08.579. Epub 2018 Aug 27.
PMID: 30205314DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Feng Lin, Gynecologist
the 1st affiliated hospital of Wenzhou Medical College
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Chief Physician
Study Record Dates
First Submitted
May 19, 2016
First Posted
January 10, 2018
Study Start
December 1, 2015
Primary Completion
June 30, 2018
Study Completion
July 30, 2018
Last Updated
January 10, 2018
Record last verified: 2017-12
Data Sharing
- IPD Sharing
- Will not share